661 related articles for article (PubMed ID: 17370648)
21. The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation.
Jin CY; Panula P
Neuroscience; 2005; 132(1):137-49. PubMed ID: 15780473
[TBL] [Abstract][Full Text] [Related]
22. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
[TBL] [Abstract][Full Text] [Related]
23. Role of the histamine system in nefopam-induced antinociception in mice.
Girard P; Pansart Y; Coppé MC; Verniers D; Gillardin JM
Eur J Pharmacol; 2004 Oct; 503(1-3):63-9. PubMed ID: 15496297
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Asakura M; Matsumura R; Itoh M
Methods Find Exp Clin Pharmacol; 1995 Nov; 17 Suppl C():64-9. PubMed ID: 8750798
[TBL] [Abstract][Full Text] [Related]
25. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
[TBL] [Abstract][Full Text] [Related]
26. The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity.
Masaki T; Yoshimatsu H
Trends Pharmacol Sci; 2006 May; 27(5):279-84. PubMed ID: 16584790
[TBL] [Abstract][Full Text] [Related]
27. The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?
Deng C; Weston-Green K; Huang XF
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):1-4. PubMed ID: 19922755
[TBL] [Abstract][Full Text] [Related]
28. (11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain.
Funke U; Vugts DJ; Janssen B; Spaans A; Kruijer PS; Lammertsma AA; Perk LR; Windhorst AD
J Labelled Comp Radiopharm; 2013; 56(3-4):120-9. PubMed ID: 24285318
[TBL] [Abstract][Full Text] [Related]
29. Histamine in the brain: beyond sleep and memory.
Passani MB; Giannoni P; Bucherelli C; Baldi E; Blandina P
Biochem Pharmacol; 2007 Apr; 73(8):1113-22. PubMed ID: 17241615
[TBL] [Abstract][Full Text] [Related]
30. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice.
Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Naghdi N; Yanai K
Pain; 2005 Nov; 118(1-2):254-62. PubMed ID: 16202530
[TBL] [Abstract][Full Text] [Related]
31. Role of the Histamine H
Schlicker E; Kathmann M
Handb Exp Pharmacol; 2017; 241():277-299. PubMed ID: 27787717
[TBL] [Abstract][Full Text] [Related]
32. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
[TBL] [Abstract][Full Text] [Related]
33. Role of H1 receptors in histamine-mediated up-regulation of STAT4 phosphorylation.
Liu Z; Kharmate G; Patterson E; Khan MM
Int Immunopharmacol; 2006 Mar; 6(3):485-93. PubMed ID: 16428084
[TBL] [Abstract][Full Text] [Related]
34. Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: A study using a knockout mouse model.
Parmentier R; Zhao Y; Perier M; Akaoka H; Lintunen M; Hou Y; Panula P; Watanabe T; Franco P; Lin JS
Neuropharmacology; 2016 Jul; 106():20-34. PubMed ID: 26723880
[TBL] [Abstract][Full Text] [Related]
35. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
Esbenshade TA; Fox GB; Cowart MD
Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
[TBL] [Abstract][Full Text] [Related]
36. [The histaminergic brain neuron system].
Zimatkin SM; Kuznetsova VB; Anishchik OV
Morfologiia; 2003; 123(2):97-105. PubMed ID: 12891790
[TBL] [Abstract][Full Text] [Related]
37. Histamine receptors in the CNS as targets for therapeutic intervention.
Passani MB; Blandina P
Trends Pharmacol Sci; 2011 Apr; 32(4):242-9. PubMed ID: 21324537
[TBL] [Abstract][Full Text] [Related]
38. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
39. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
[TBL] [Abstract][Full Text] [Related]
40. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
